Keros Therapeutics Inc. (KROS) Share

Keros Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat musculoskeletal and hematological disorders. The company's research and development efforts are centered on understanding and manipulating the transforming growth factor-beta (TGF-β) superfamily signaling pathways, which play a crucial role in regulating cell growth, differentiation, and tissue repair. Keros Therapeutics aims to develop innovative therapies that address unmet medical needs in areas such as pulmonary arterial hypertension (PAH), fibrosis, and anemia. By targeting specific pathways within the TGF-β superfamily, Keros Therapeutics seeks to create targeted treatments with improved efficacy and safety profiles. The company is committed to advancing its pipeline of drug candidates through clinical trials and ultimately bringing new treatment options to patients.